VAM
ATRC icon

Visium Asset Management’s AtriCure ATRC Stock Holding History

Visium Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-78,703
Closed -$1.45M – 1035
2014
Q2 		$1.45M Buy
+78,703
New +$1.31M 0.02% 469

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Visium Asset Management's ATRC Position: Q3 2014 in Review

Visium Asset Management sold out of AtriCure (ATRC) in Q3 2014, closing a stake of 78,703 shares — an estimated $1.45M sold.

Visium Asset Management first reported a position in ATRC in Q2 2014 and held it in 1 quarter. The position peaked at $1.45M in Q2 2014. 112 funds tracked by Wall St. Rank hold ATRC as of Q3 2014.

  • Visium Asset Management reported no remaining AtriCure position as of Q3 2014 after selling out during the quarter.
  • Visium Asset Management sold 78,703 AtriCure shares in Q3 2014, an estimated $1.45M.
  • Visium Asset Management first reported a position in AtriCure in Q2 2014 and held it in 1 quarter.
  • Visium Asset Management's AtriCure position peaked at $1.45M in Q2 2014.
  • 112 funds tracked by Wall St. Rank held AtriCure as of Q3 2014.

Based on Visium Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.